Interleukin Genetics, Molecular Skin, University of Sheffield deal

ILGN received about 5% of the outstanding equity of Molecular SkinCare in exchange for granting to Molecular SkinCare and Asterion Ltd. (Sheffield, U.K.) rights to certain IP originally licensed to I...